Stephanie Hampp

Biallelic germline BRCA1 mutations in a patient with early onset breast cancer, mild Fanconi anemia‐like phenotype, and no chromosome fragility

L. Wiesmüller, R. Schmutzler, J. Surrallés, 2019, Molecular genetics & genomic medicine.

The C-terminal domain of p 53 orchestrates the interplay between non-covalent and covalent poly ( ADP-ribosyl ) ation of p 53 by PARP 1

L. Wiesmüller, K. Hauser, A. Hartwig, 2018 .

The C-terminal domain of p53 orchestrates the interplay between non-covalent and covalent poly(ADP-ribosyl)ation of p53 by PARP1

L. Wiesmüller, K. Hauser, A. Hartwig, 2017, Nucleic acids research.

In vitro model for DNA double‐strand break repair analysis in breast cancer reveals cell type–specific associations with age and prognosis

L. Wiesmüller, W. Janni, M. Ihle, 2016, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

DNA damage tolerance pathway involving DNA polymerase ι and the tumor suppressor p53 regulates DNA replication fork progression

H. Pospiech, L. Wiesmüller, V. Gottifredi, 2016, Proceedings of the National Academy of Sciences.

Modulation of the poly (ADP-ribose) polymerase inhibitor response and DNA recombination in breast cancer cells by drugs affecting endogenous wild-type p53.

L. Wiesmüller, G. Selivanova, M. Troester, 2014, Carcinogenesis.

Characterization of the nonallelic homologous recombination hotspot PRS3 associated with type‐3 NF1 deletions

Antje M Zickler, H. Kestler, D. Cooper, 2012, Human mutation.

ATM Deficiency Generating Genomic Instability Sensitizes Pancreatic Ductal Adenocarcinoma Cells to Therapy-Induced DNA Damage.

E. Schröck, L. Wiesmüller, T. Seufferlein, 2017, Cancer research.

Therapeutic targeting of mutant p53 in pediatric acute lymphoblastic leukemia

L. Wiesmüller, C. Eckert, S. Stilgenbauer, 2019, Haematologica.